Ginsenoside Rg3 Sensitizes Colorectal Cancer to Radiotherapy through Downregulation of Proliferative and Angiogenic Biomarkers

Figure 1

Tumor growth over time in the different treatment groups of mice. (Blue) controls, (red) radiation-treated, (green) Rg3-treated, and (purple) combined Rg3 and radiation-treated mice. All data are expressed as mean.